Venture-Backed Startups

DiabeTech develops an AI-powered biosensor sock and mobile platform to detect diabetic foot complications and ulcers at an early stage, serving patients and healthcare providers. The company operates in the digital health and medical device space, partnering with healthcare systems and clinics across the United States.

1 investor

A nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.

1 investor

Diabetes Reversal Group (DRG) offers a patented, non-drug program for people with Type 2 Diabetes that combines dietary guidance, nutritional supplements, and exercise to reduce or eliminate reliance on glucose-lowering medications under medical supervision. The program is delivered through affiliated clinics to diabetic patients internationally.

0 investors

ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.

1 investor

Diaceutics operates DXRX, a diagnostic commercialization platform that integrates real-world lab, genomic, clinical, claims, and social-determinants data to help pharma and biotech companies commercialize precision-medicine therapies. Its tools identify testing behaviors and engage physicians to close the gap between diagnostic testing and treatment adoption.

1 investor

Diadem Bio develops therapeutic treatments designed to be safe, powerful, versatile and cost-effective for patients with unmet medical needs, with a focus on potential cancer cures and other difficult diseases.

1 investor

Diadem operates a curated deal-flow platform that connects startups with funds, family offices, lenders, and angel investors through AI and human filtering. It matches founders and investors based on real meetings and stated investment theses rather than data scraping, providing introductions with context.

1 investor

Diadem is a diagnostics company developing AlzoSure, a plasma/blood-based test that uses a proprietary antibody targeting a specific conformation of the p53 protein to predict and diagnose Alzheimer's disease. The test aims to provide early, non-invasive diagnosis and to support patient recruitment for Alzheimer's drug development clinical trials.

1 investor

Diag-Nose.io develops precision diagnostics and therapies for respiratory diseases including asthma, COPD, and sinusitis by combining nasal microsampling, proteomics, and machine learning to analyze airway biology. The company serves respiratory specialists, biotech companies, pharmaceutical firms, and researchers.

2 investors

Hologic Diagenode provides epigenomics profiling services and sample preparation products for next-generation sequencing, proteomics, and epigenetics research. It serves biomarker discovery and validation through epigenomics and bioinformatics for research applications.

1 investor

0 investors

Diagna builds AI technology to automate administrative work in healthcare clinics, helping medical staff focus on patient care by handling information management tasks like form processing, faxes, and data coordination.

1 investor

1 investor

Diagnoly develops real-time AI software that assists clinicians during fetal ultrasound scans to improve detection. Its product targets medical practitioners in prenatal diagnostics.

1 investor

Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.

0 investors

0 investors

Diagnostic Robotics develops an AI engine for healthcare that aims to improve efficiency and accessibility in clinical operations. The company serves healthcare providers and payers to optimize processes and decision-making.

3 investors

0 investors

Diagnostikare is a physician-designed digital health platform that combines technology with human support to deliver reliable, people-centered healthcare experiences. It offers companies an integrated solution to support employee health and improve health-related decision-making.

1 investor

DIAGNOSTYKA operates a network of medical sample collection points and offers laboratory tests and test packages, including online purchase, results retrieval, and online consultations. It serves patients in Poland seeking diagnostic laboratory testing.

1 investor

Backline is a healthcare communication and coordination platform that helps hospital teams manage clinical workflows like care coordination, consults, patient engagement, and case management. Part of DrFirst, it provides task accountability and escalation features built on secure messaging infrastructure trusted by 1,500+ healthcare facilities.

1 investor

Xoilac TV is a Vietnamese-language website that streams live football (soccer) matches for free, covering leagues such as the Premier League, La Liga, Serie A, Bundesliga, Champions League, and regional competitions. It also provides match schedules, standings, betting analysis/predictions, and football news.

1 investor

Diagon operates a marketplace connecting buyers and sellers of surplus manufacturing equipment to address supply chain inefficiencies and support reshoring trends in North America. The platform enables equipment sourcing at optimized pricing and timing for manufacturing operations.

5 investors

Diagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases. Its DIAGONAL Product Engine uses computational and experimental methods to identify clustering antibodies across receptor classes, with a lead candidate (DIAG723) in a Phase 1/2 trial for Hereditary Hemorrhagic Telangiectasia.

4 investors